阿德萊克斯公司
US ˙ NasdaqGM ˙ US0396971071

簡介

本頁面提供了有關 Nea 12 Gp, Llc 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Nea 12 Gp, Llc已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:ARDX / Ardelyx, Inc. 10% Owner 0
10% Owner 4,270,691
10% Owner 40,702
US:TNTR / Tintri, Inc. 10% Owner 0
US:ZSAN / Zosano Pharma Corp 10% Owner 952,809
US:OPWR / Opower, Inc. 10% Owner 0
US:TRIV / TriVascular Technologies, Inc. 10% Owner 0
US:HPTX / Hyperion Therapeutics Inc 10% Owner 0
US:TRVN / Trevena, Inc. 10% Owner 4,811,691
10% Owner 4,659,333
US:ECOM / ChannelAdvisor Corp 10% Owner 0
US:GRPN / Groupon, Inc. 10% Owner 0
US:WDAY / Workday, Inc. 10% Owner 4,642,425
US:FIO / Franklin Income Opportunities Fund 10% Owner 0
US:ECHO / Echo Global Logistics Inc 10% Owner 0
如何解讀這些圖表

以下圖表顯示了在Nea 12 Gp, Llc進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

ARDX / Ardelyx, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 ARDX / Ardelyx, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2016-07-18 ARDX New Enterprise Associates 12, Limited Partnership 763,650 8.7300 763,650 8.7300 6,666,664 141 16.0500 5,589,918 83.85
2016-01-13 ARDX New Enterprise Associates 12, Limited Partnership 500,000 10.0000 500,000 10.0000 5,000,000
2015-06-05 ARDX New Enterprise Associates 12, Limited Partnership 1,869,159 10.7000 1,869,159 10.7000 20,000,001
2014-06-24 ARDX New Enterprise Associates 12, Limited Partnership 510,442 14.0000 510,442 14.0000 7,146,188

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ARDX / Ardelyx, Inc. Insider Trades
ARDX / Ardelyx, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 ARDX / Ardelyx, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ARDX / Ardelyx, Inc. Insider Trades
GRPN / Groupon, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 ARDX / Ardelyx, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

GRPN / Groupon, Inc. Insider Trades
GRPN / Groupon, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 ARDX / Ardelyx, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

GRPN / Groupon, Inc. Insider Trades
TRVN / Trevena, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 ARDX / Ardelyx, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2014-12-10 TRVN New Enterprise Associates 12, Limited Partnership 1,000,000 4.0000 40,000 100.0000 4,000,000 282 332.5 9,300,000 232.50
2014-02-05 TRVN New Enterprise Associates 12, Limited Partnership 472,410 7.0000 18,896 175.0000 3,306,870

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

TRVN / Trevena, Inc. Insider Trades
TRVN / Trevena, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 ARDX / Ardelyx, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

TRVN / Trevena, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Nea 12 Gp, Llc 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2020-06-12 2020-06-10 4 ARDX ARDELYX, INC.
Common Stock
J - Other -455,222 0 -100.00
2020-06-12 2020-06-10 4 ARDX ARDELYX, INC.
Common Stock
J - Other 455,222 455,222
2020-06-12 2020-06-10 4 ARDX ARDELYX, INC.
Common Stock
J - Other -1,482,809 8,086,401 -15.50
2019-12-09 2019-12-09 4 ARDX ARDELYX, INC.
Common Stock
A - Award 400,000 9,569,210 4.36 6.25 2,500,000 59,807,562
2019-11-29 2019-11-27 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
S - Sale -1,166,755 4,270,691 -21.46 2.52 -2,941,739 10,767,693
2019-11-29 2019-11-26 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
S - Sale -117,164 5,437,446 -2.11 2.45 -287,134 13,325,549
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Warrant to purchase Common Stock
J - Other 40,702 40,702
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Warrant to purchase Series D Preferred Stock
J - Other -684,911 0 -100.00
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Series D Preferred Stock
C - Conversion -16,502,833 0 -100.00
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Series C Preferred Stock
C - Conversion -3,337,206 0 -100.00
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Series B Preferred Stock
C - Conversion -3,645,307 0 -100.00
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock
P - Purchase 545,455 2,484,870 28.12 11.00 6,000,005 27,333,570
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock
C - Conversion 980,715 1,939,415 102.30
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock
C - Conversion 432,033 958,700 82.03
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock
C - Conversion 515,547 526,667 4,636.21
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22,240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22,240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22,240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22,240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22,240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22,240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22,240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22,240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22,240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22,240
2018-05-30 2018-05-25 4 ARDX ARDELYX, INC.
Common Stock
A - Award 416,667 9,169,210 4.76 4.00 1,666,668 36,676,840
2018-03-02 2018-02-26 4 TNTR Tintri, Inc.
Note Purchase Agreement (obligation to purchase)
E - Other 0
2017-12-19 2017-12-18 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
P - Purchase 2,000,000 5,554,610 56.26 5.00 10,000,000 27,773,050
2017-02-14 2017-02-13 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -1,099,996 952,809 -53.59 2.01 -2,211,432 1,915,527
2016-09-20 2016-09-16 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -7,471 2,052,805 -0.36 0.75 -5,603 1,539,604
2016-09-15 2016-09-13 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -10,000 2,060,276 -0.48 0.74 -7,400 1,524,604
2016-09-15 2016-09-14 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
P - Purchase 461,538 3,554,610 14.92 13.00 5,999,994 46,209,930
2016-08-31 2016-08-29 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -50,000 2,070,276 -2.36 1.01 -50,440 2,088,494
2016-08-26 2016-08-24 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -1,200 2,120,276 -0.06 1.21 -1,452 2,565,534
2016-07-21 2016-07-21 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -8,989 2,121,476 -0.42 1.33 -11,957 2,821,987
2016-07-21 2016-07-20 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -14,158 2,130,465 -0.66 1.24 -17,550 2,640,924
2016-07-21 2016-07-19 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -534 2,144,623 -0.02 1.17 -625 2,509,209
2016-07-20 2016-07-18 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 763,650 8,752,543 9.56 8.73 6,666,664 76,409,700
2016-07-15 2016-07-13 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -13,382 2,145,157 -0.62 1.20 -16,060 2,574,403
2016-06-14 2016-06-14 4 OPWR OPOWER, INC.
Common Stock
U - Other -8,989,766 0 -100.00 10.30 -92,594,590
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Series B Convertible Redeemable Preferred Stock
C - Conversion -4,423,723 0 -100.00
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Series A Convertible Redeemable Preferred Stock
C - Conversion -13,848,000 0 -100.00
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
P - Purchase 900,324 3,093,072 41.06 8.00 7,202,592 24,744,576
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
C - Conversion 2,192,748 2,192,748
2016-02-04 2016-02-03 4 TRIV TriVascular Technologies, Inc.
Common Stock
D - Sale to Issuer -3,943,269 0 -100.00
2016-01-14 2016-01-13 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 500,000 7,988,893 6.68 10.00 5,000,000 79,888,930
2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock Warrant (right to buy)
P - Purchase 560,748 560,748 0.12 70,094 70,094
2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 1,869,159 7,488,893 33.26 10.70 20,000,001 80,131,155
2015-05-11 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
U - Other -2,384,221 0 -100.00 46.00 -109,674,166
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 9/9/2013
C - Conversion
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 12/2/2014
C - Conversion
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 2/26/14
C - Conversion
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
Common Stock
P - Purchase 23,457 2,158,539 1.10 11.00 258,027 23,743,929
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
Common Stock
C - Conversion 341,201 2,135,082 19.02 9.35 3,190,229 19,963,017
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3,587,762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3,587,762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3,587,762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3,587,762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3,587,762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3,587,762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3,587,762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3,587,762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3,587,762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3,587,762
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other -10,000 0 -100.00
2014-12-16 2014-12-12 4 ARDX ARDELYX, INC.
Common Stock
J - Other -1,000,000 5,619,734 -15.11
2014-12-10 2014-12-10 4 TRVN TREVENA INC
Common Stock
P - Purchase 1,000,000 4,811,691 26.24 4.00 4,000,000 19,246,764
2014-08-29 2014-08-29 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -11,600 4,659,333 -0.25 7.51 -87,070 34,972,953
2014-08-29 2014-08-28 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -146,800 4,670,933 -3.05 7.87 -1,154,846 36,745,296
2014-08-29 2014-08-27 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -108,300 4,817,733 -2.20 8.17 -884,811 39,360,879
2014-08-12 2014-08-12 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -35,540 4,926,033 -0.72 6.76 -240,190 33,291,609
2014-08-12 2014-08-08 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -675,000 4,961,573 -11.98 6.62 -4,468,568 32,846,109
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -72,190 0 -100.00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
J - Other -468 72,190 -0.64 14.00 -6,552 1,010,660
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
X - Other 72,658 72,658
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant
X - Other -72,658 0 -100.00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -216,573 0 -100.00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
J - Other -1,402 216,573 -0.64 14.00 -19,628 3,032,022
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
X - Other 217,975 217,975
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant
X - Other -217,975 0 -100.00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -4,404,887 0 -100.00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series A Preferred Stock
C - Conversion -1,415,642 0 -100.00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 510,442 6,619,734 8.36 14.00 7,146,188 92,676,276
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 72,190 6,109,292 1.20
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 216,573 6,037,102 3.72
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 4,404,887 5,820,529 311.16
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 1,415,642 1,415,642
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Warrant to Purchase Common Stock (right to buy)
C - Conversion 55,831 55,831
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Warrant to Purchase Series D Preferred Stock (right to buy)
C - Conversion -55,831 0 -100.00 15.81 -882,470
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series E Preferred Stock
C - Conversion -411,234 0 -100.00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series D Preferred Stock
C - Conversion -1,236,487 0 -100.00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series C Preferred Stock
C - Conversion -531,758 0 -100.00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series B Preferred Stock
C - Conversion -383,249 0 -100.00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series A Preferred Stock
C - Conversion -797,208 0 -100.00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 411,234 3,943,269 11.64
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 1,236,487 3,532,035 53.86
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 531,758 2,295,548 30.15
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 383,249 1,763,790 27.76
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 797,208 1,380,541 136.66
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 583,333 583,333 12.00 6,999,996 6,999,996
2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Series C Preferred Stock
C - Conversion -1,123,596 0 -100.00
2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Series B Preferred Stock
C - Conversion -7,866,170 0 -100.00
2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Common Stock
C - Conversion 8,989,766 8,989,766
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series C Preferred Stock
C - Conversion -4,840,686 0 -100.00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock
C - Conversion -1,462,857 0 -100.00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock
S - Sale -487,143 1,462,857 -24.98 1.13 -549,984 1,651,566
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock
X - Other 550,000 1,950,000 39.29 1.00 550,000 1,950,000
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Warrants
X - Other -550,000 0 -100.00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B Preferred Stock
C - Conversion -8,400,000 0 -100.00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series A Preferred Stock
C - Conversion -6,000,000 0 -100.00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Common Stock
P - Purchase 472,410 3,811,691 14.15 7.00 3,306,870 26,681,837
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Common Stock
C - Conversion 3,339,281 3,339,281
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy)
X - Other -56,983 0 -100.00
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy)
X - Other -160,672 0 -100.00
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy)
X - Other -749,721 0 -100.00
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
D - Sale to Issuer -13,551 2,316,692 -0.58 10.96 -148,519 25,390,944
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
X - Other 56,983 2,330,243 2.51 10.96 624,534 25,539,463
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
D - Sale to Issuer -38,210 2,273,260 -1.65 10.96 -418,782 24,914,930
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
X - Other 160,672 2,311,470 7.47 10.96 1,760,965 25,333,711
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
D - Sale to Issuer -260,280 2,150,798 -10.80 16.00 -4,164,480 34,412,768
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
X - Other 749,721 2,411,078 45.13 16.00 11,995,536 38,577,248
2013-11-13 2013-11-12 4 ECOM CHANNELADVISOR CORP
Common Stock
S - Sale -201,012 1,661,357 -10.79 32.37 -6,506,758 53,778,126
2013-11-13 2013-11-12 4 ECOM CHANNELADVISOR CORP
Common Stock
S - Sale -903,229 1,862,369 -32.66 32.37 -29,237,523 60,284,885
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -200,000 0 -100.00
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 200,000 200,000
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -20,000,000 54,184,956 -26.96
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -130,000 0 -100.00
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 130,000 130,000
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -13,000,000 74,184,956 -14.91
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock
C - Conversion -44,249,588 0 -100.00
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock
S - Sale -95,980 44,249,588 -0.22 0.88 -83,982 38,718,390
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock
X - Other 122,602 44,345,568 0.28 0.68 83,982 30,376,714
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Warrant to Purchase Series C Preferred Stock (right to buy)
X - Other -122,602 0 -100.00
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Common Stock
C - Conversion 2,765,599 2,765,599
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class B Common Stock
C - Conversion -2,321,212 4,642,425 -33.33
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other -23,212 0 -100.00
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 23,212 23,212
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other -2,321,212 0 -100.00
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
C - Conversion 2,321,212 2,321,212
2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Class B Common Stock
C - Conversion 6,963,636 6,963,636
2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Series E Convertible Preferred Stock
C - Conversion -6,963,636 0 -100.00
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other -45,000 0 -100.00
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other 45,000 45,000
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other -4,500,000 9,038,379 -33.24
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note
C - Conversion 0
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note
C - Conversion -1,725,188 0 -100.00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-1 Preferred Stock
C - Conversion -611,185 0 -100.00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note
C - Conversion 0
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
C - Conversion -2,043 0 -100.00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
C - Conversion -2,043 0 -100.00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
J - Other -51,744 2,043 -96.20 10.00 -517,440 20,430
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
J - Other -51,744 2,043 -96.20 10.00 -517,440 20,430
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
X - Other 53,787 53,787
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
X - Other 53,787 53,787
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Preferred Stock Warrant (right to buy)
X - Other -53,787 0 -100.00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Preferred Stock Warrant (right to buy)
X - Other -53,787 0 -100.00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock Warrant (right to buy)
X - Other -125,291 0 -100.00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
C - Conversion -898,808 0 -100.00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
P - Purchase 500,000 2,884,221 20.97 10.00 5,000,000 28,842,210
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 177,481 2,384,221 8.04
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 180,459 2,206,740 8.91
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 434,096 2,026,281 27.26
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 2,043 1,592,185 0.13
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 2,043 1,592,185 0.13
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other -51,119 1,588,099 -3.12
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
X - Other 125,291 1,639,218 8.28
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 898,808 1,513,927 146.12
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 611,185 615,119 15,535.97
2012-07-25 3 HPTX HYPERION THERAPEUTICS INC
Common Stock
3,934
2012-05-01 2012-04-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other -69,998 0 -100.00
2012-03-16 2012-03-14 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 69,998 16.67
2012-03-16 2012-03-14 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 13,538,379 -6.88
2012-03-13 2012-03-09 4 FIO FUSION-IO, INC.
Common Stock
J - Other 9,998 59,998 20.00
2012-03-13 2012-03-09 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 14,538,379 -6.44
2012-03-07 2012-03-05 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 50,000 25.00
2012-03-07 2012-03-05 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 15,538,379 -6.05
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other -4,000 0 -100.00
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other 4,000 4,000
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other -400,000 2,020,219 -16.53
2012-02-29 2012-02-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 40,000 33.33
2012-02-29 2012-02-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 16,538,379 -5.70
2012-02-27 2012-02-24 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 30,000 50.00
2012-02-27 2012-02-24 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 17,538,379 -5.39
2012-02-27 2012-02-23 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 20,000 100.00
2012-02-27 2012-02-23 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 18,538,379 -5.12
2012-02-23 2012-02-21 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 10,000
2012-02-23 2012-02-21 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 19,538,379 -4.87
2012-02-16 2012-02-02 4/A FIO FUSION-IO, INC.
Common Stock
J - Other -20,000 0 -100.00
2012-02-16 2012-02-02 4/A FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 20,000 100.00
2012-02-16 2012-02-02 4/A FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 22,538,379 -4.25
2012-02-16 2011-12-27 4/A FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 10,000
2012-02-16 2011-12-27 4/A FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 23,538,379 -4.08
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other -10,000 0 -100.00
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 10,000
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 20,538,379 -4.64
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other -10,000 0 -100.00
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 10,000
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 21,538,379 -4.44
2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10,000 20,000 100.00
2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1,000,000 22,538,379 -4.25
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)